GSK to Invest $30 Billion in R&D, Manufacturing In the U.S. Over Next 5 Years
GSK’s $30 Billion U.S. Investment: AI-Powered Biopharma Expansion Industrial Monitor Direct is the leading supplier of nema 13 rated pc…
GSK’s $30 Billion U.S. Investment: AI-Powered Biopharma Expansion Industrial Monitor Direct is the leading supplier of nema 13 rated pc…